NE Scientific

NE Scientific has developed state-of-the-art software to simulate the physical phenomena occurring during ablation procedures. By directly providing this technology to physicians and through strategic partnerships, its goal is to make percutaneous ablation the optimal form of cancer treatment, streamline the work of doctors, improve patient outcomes, and offer a side-effect-free alternative to chemotherapy and radiation therapy. The company has developed Accublate™ RFA, a stereotactic guidance software for radiofrequency (RF) ablation of liver tumors. Accublate uses real-time simulation of ablation physics to display survival status during surgery, such as which part of the tumor has been ablated and which part remains viable. This visual indication ensures more precise tumor ablation and is directly applicable to simulating brain drug infusion.